VIUM Capital recorded its highest revenue producing year in the firm’s young history, closing 56 transactions totaling nearly $900 million in par in 2024. The financings varied from bridge to permanent debt (both taxable and tax-exempt) and funded 82 separate properties in more than a dozen states across the country. Of the financings, 37 were HUD/GNMA loans through HUD’s 232/223(f) program, totaling over $450 million of par. VIUM finished the 2024 fiscal year as the #2 ranked HUD healthcare lender in the country in both total volume and number of transactions closed.
The year also witnessed VIUM’s HUD/GNMA servicing book surpassing $1 billion, securing multiple HUD Corporate Credit Review approvals for clients, and the firm completing a $630 million securitization of its healthcare bridge loans, its second securitization in as many years. VIUM’s nearly $3 billion healthcare bridge book is performing solidly, with an average LTV of 66% and global debt service coverage ratio averaging well-above performance covenant levels.
